Literature DB >> 21666762

Inhaled Corticosteroids Adverse Events In Asthmatic Children: A Review.

Saad Alotaibi1, Farhan Alshammari.   

Abstract

BACKGROUND: Inhaled corticosteroids (ICS) have an important role in the treatment of chronic asthma in children. The prevalence of asthma symptoms in children varies from 0 to 30 percent in different populations with the highest prevalence occurring in Australia, New Zealand and England.
METHODS: A review of the literature and studies about inhaled corticosteroids safety, action and adverse events in children and adults where applicable was done.
CONCLUSION: Inhaled corticosteroids are the main stay therapy for persistent asthma in children. Their safety and efficacy is proven from the literature. Proper education of the parents about asthma and inhaled corticosteroids is very important and improve asthma control. Keeping in mind to taper the inhaled corticosteroids to the lowest dose needed to control asthma and using correct inhalation technique by the use of spacers with metered dose inhalers or dry powder inhalers (Turbuhaler and Diskus) will prevent the occurrence of adverse events.

Entities:  

Year:  2006        PMID: 21666762      PMCID: PMC3111016          DOI: 10.5580/11af

Source DB:  PubMed          Journal:  Internet J Pediatr Neonatol        ISSN: 1528-8374


  35 in total

1.  A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial.

Authors:  L A Laitinen; A Laitinen; T Haahtela
Journal:  J Allergy Clin Immunol       Date:  1992-07       Impact factor: 10.793

Review 2.  Anti-inflammatory actions of steroids: molecular mechanisms.

Authors:  P J Barnes; I Adcock
Journal:  Trends Pharmacol Sci       Date:  1993-12       Impact factor: 14.819

Review 3.  Establishing a therapeutic index for the inhaled corticosteroids: part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids.

Authors:  H W Kelly
Journal:  J Allergy Clin Immunol       Date:  1998-10       Impact factor: 10.793

Review 4.  Inhaled glucocorticoids for asthma.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  1995-03-30       Impact factor: 91.245

Review 5.  Effect of corticosteroids on airway hyperresponsiveness.

Authors:  P J Barnes
Journal:  Am Rev Respir Dis       Date:  1990-02

6.  Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects.

Authors:  P H Brown; S P Matusiewicz; C Shearing; L Tibi; A P Greening; G K Crompton
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

Review 7.  Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.

Authors:  S M Holliday; D Faulds; E M Sorkin
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

8.  Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate.

Authors:  P König; L Hillman; C Cervantes; C Levine; C Maloney; B Douglass; L Johnson; S Allen
Journal:  J Pediatr       Date:  1993-02       Impact factor: 4.406

9.  Inhaled budesonide for treatment of recurrent wheezing in early childhood.

Authors:  H Bisgaard; S L Munck; J P Nielsen; W Petersen; S V Ohlsson
Journal:  Lancet       Date:  1990-09-15       Impact factor: 79.321

10.  A meta-analysis of the effect of oral and inhaled corticosteroids on growth.

Authors:  D B Allen; M Mullen; B Mullen
Journal:  J Allergy Clin Immunol       Date:  1994-06       Impact factor: 10.793

View more
  2 in total

1.  Inhaled steroid-induced mania in an adolescent girl: a case report.

Authors:  Saira Khan; Jabeen Hayat; Shakeel Raza
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  Neuropsychiatric manifestation of the drugs used in the treatment of SARS-2-CoV-2019 (COVID-19) infection and their management: An overview and practice implications.

Authors:  Akash Kumar; Ankita Chattopadhyay; Snehil Gupta
Journal:  Asian J Psychiatr       Date:  2022-04-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.